Textiles, Apparel and Luxury Goods
Company Overview of PurThread Technologies, Inc.
PurThread Technologies, Inc. engages in the research, development, manufacture, and sale of antimicrobial textile products. Its products include healthcare textiles, such as privacy curtains, sheets, scrubs, blankets, and lab coats; specialty nylon and polyester fibers and yarns for use in military apparel; and hospital curtains, scrubs, doctor and lab coats, and hospital linens and blankets for military hospitals. The company also offers fibers and yarns for use in sports products, home products, industrial goods, and intimates. Its products incorporate EPA-registered antimicrobials to reduce odor, staining, and mildew. PurThread Technologies, Inc. was incorporated in 2009 and is based in P...
47 Hulfish Street
Princeton, NJ 08542
Founded in 2009
Key Executives for PurThread Technologies, Inc.
Chief Executive Officer and President
Chief Technical Officer and Director
Vice President of Infection Control Applications
Vice President of Consumer & Military Applications
Senior Director of Sales for Northeast Region
Compensation as of Fiscal Year 2014.
PurThread Technologies, Inc. Key Developments
Eastman Kodak Company and PurThread Technologies to Collaborate on Antimicrobial Surface Solutions for Healthcare and Military
Feb 18 14
Eastman Kodak Company and PurThread Technologies, Inc. have entered a joint development agreement (JDA). The collaboration will expand the use of Kodak's proprietary antimicrobial technology to hard and soft surfaces. Kodak brings to the JDA expertise in materials science, such as nanoparticle and dispersion technologies, while PurThread brings extensive knowledge of textile manufacturing technologies, product formulation, and a keen understanding of the healthcare market. Kodak's proprietary silver-based antimicrobial technology is at the center of the JDA. PurThread holds a globally exclusive agreement to use Kodak's antimicrobial agent in textiles. The company embeds Kodak's EPA-registered antimicrobial agent, a proprietary version of a silver salt, into synthetic fibers before they are spun into yarn and woven into fabrics. This ensures that the antimicrobial effects of the fabric are uniform and constant throughout the life of the product. A double-blind randomized controlled trial, published in the Journal Infection Control and Hospital Epidemiology, found that hospital privacy curtains made of PurThread fabric resisted contamination seven times longer than standard curtains. Curtains without PurThread fabric were also eight times more likely to be contaminated with the superbug VRE (Vancomycin-Resistant Enterococci), compared to PurThread's curtains. Currently, PurThread's product line includes healthcare textiles, such as medical scrubs, lab coats, privacy curtains and linens, as well as fitness apparel, such as polo shirts and base layers. The company is also partnering with leaders in the US textile industry to manufacture its products and bring its next-generation technology to discerning consumer brands.
PurThread Technologies, Inc. Announces Executive Appointments
Jul 30 13
PurThread Technologies has added two powerhouses to its team who have the track records to guide the company through its next phase of rapid growth. Healthcare sales, marketing and executive management professional Lisa T. Grimes will lead PurThread as President & Chief Executive Officer. Meanwhile, Dr. Tom Inglesby, Director and Chief Executive Officer of the University of Pittsburgh Medical Center (UPMC), Center for Health Security, joins the PurThread Board of Directors, bringing with him significant expertise in public health policy. With 28 years of experience in the life sciences industry, Grimes brings a wealth of deep domain expertise to the table. She was formerly CEO of InSite Clinical Trials, a full service contract research organization, which was acquired by United Healthcare. Prior to InSite Clinical Trials, Grimes served as Vice President of Business Development for Pharmaceutical Product Development. She served for ten years as a member of the Executive Advisory Group of Campbell Alliance and its subsidiary, the Pharmaceutical Institute. In his role as Director and CEO of the UPMC Center for Health Security, Dr. Inglesby is internationally recognized in the fields of public health preparedness, pandemic flu and epidemic planning, and biosecurity. His expertise is widely recognized throughout the medical field, having authored or co-authored over 80 peer-reviewed articles, reports, and commentaries on a spectrum of health and security issues.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 1, 2013